Market Closed -
Other stock markets
|
After hours 03:30:06 pm | |||
374.35 EUR | +0.09% |
|
377.72 | +0.90% |
05:34am | Enorama Pharma Appoints New Commercial Director - Takes Office in September | FW |
05:11am | L'ORÉAL : UBS still on hold ahead of quarterly results | CF |
Capitalization | 200B 234B 186B 172B 321B 20,055B 358B 2,229B 848B 9,369B 877B 859B 34,282B | P/E ratio 2025 * |
30.1x | P/E ratio 2026 * | 27.6x |
---|---|---|---|---|---|
Enterprise value | 199B 233B 186B 172B 320B 20,007B 358B 2,224B 846B 9,347B 875B 857B 34,201B | EV / Sales 2025 * |
4.47x | EV / Sales 2026 * | 4.23x |
Free-Float |
42.92% | Yield 2025 * |
1.9% | Yield 2026 * | 2.05% |
More valuation ratios
* Estimated data
More news
Last Transcript: L'Oréal
L'ORÉAL : UBS still on hold ahead of quarterly results | 05:11am | CF |
LOREAL : UBS reaffirms its Neutral rating | Jul. 08 | ZD |
LOREAL : Deutsche Bank gives a Sell rating | Jul. 04 | ZD |
LOREAL : Deutsche Bank keeps a Sell rating | Jun. 23 | ZD |
LOREAL : Jefferies sticks Neutral | Jun. 20 | ZD |
More press releases
More news
1 day | +0.09% | ||
1 week | +0.40% | ||
Current month | +3.10% | ||
1 month | -1.20% | ||
3 months | +11.55% | ||
6 months | +12.79% | ||
Current year | +9.51% |
1 week | 367.15 | ![]() | 377.2 |
1 month | 348.35 | ![]() | 383.25 |
Current year | 323.7 | ![]() | 394.68 |
1 year | 316.3 | ![]() | 413.45 |
3 years | 300.7 | ![]() | 461.85 |
5 years | 269.3 | ![]() | 461.85 |
10 years | 140.4 | ![]() | 461.85 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 2021-04-30 | |
Director of Finance/CFO | 59 | 2019-02-07 | |
Antoine Vanlaeys
COO | Chief Operating Officer | - | 2021-01-31 |
Director | Title | Age | Since |
---|---|---|---|
Jean-Paul Agon
CHM | Chairman | 69 | 2011-02-28 |
Director/Board Member | 61 | 2021-04-30 | |
Director/Board Member | 39 | 2012-02-12 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
3.45% | 21 M€ | +3.63% | - | |
3.22% | 137 M€ | +14.17% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.09% | +0.40% | -6.42% | +13.61% | 234B | ||
+1.45% | +7.31% | +72.99% | - | 37.08B | ||
+0.88% | +2.03% | +0.15% | +14.61% | 20.52B | ||
+3.17% | +0.96% | -43.50% | -52.54% | 6.95B | ||
+1.05% | -2.04% | -11.03% | +1.28% | 6.01B | ||
+1.12% | +0.91% | -18.19% | -25.49% | 4.51B | ||
-0.44% | -2.09% | +16.58% | +92.15% | 4.35B | ||
+0.10% | -3.14% | -50.20% | -34.18% | 4.31B | ||
-0.79% | -0.79% | +101.36% | - | 4.16B | ||
+1.40% | -0.40% | +84.90% | - | 4.12B | ||
Average | +0.84% | +1.15% | +14.66% | +1.35% | 32.6B | |
Weighted average by Cap. | +0.43% | +1.18% | +4.24% | +11.64% |
2025 * | 2026 * | |
---|---|---|
Net sales | 44.55B 52.16B 41.52B 38.4B 71.47B 4,471B 79.89B 497B 189B 2,089B 196B 192B 7,643B | 46.54B 54.49B 43.38B 40.12B 74.66B 4,671B 83.47B 519B 198B 2,182B 204B 200B 7,985B |
Net income | 6.67B 7.81B 6.21B 5.75B 10.7B 669B 11.96B 74.37B 28.3B 313B 29.28B 28.67B 1,144B | 7.23B 8.47B 6.74B 6.23B 11.6B 726B 12.97B 80.68B 30.7B 339B 31.76B 31.1B 1,241B |
Net Debt | -472M -552M -440M -407M -757M -47.36B -846M -5.26B -2B -22.12B -2.07B -2.03B -80.95B | -3.07B -3.59B -2.86B -2.64B -4.92B -308B -5.5B -34.22B -13.02B -144B -13.47B -13.19B -526B |
More financial data
* Estimated data
Employees
94,397
Sector
Personal Products
Calendar
Jul. 28
- Q2 2025 Earnings Release
Date | Price | Change | Volume |
---|---|---|---|
25-07-09 | 374.35 € | +0.09% | 308,300 |
25-07-08 | 374.00 € | +0.34% | 273,327 |
25-07-07 | 372.75 € | +0.76% | 238,536 |
25-07-04 | 369.95 € | -0.78% | 223,764 |
25-07-03 | 372.85 € | 0.00% | 186,062 |
Real-time Euronext Paris, July 09, 2025 at 11:55 am EDT
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
374.00EUR
Average target price
382.28EUR
Spread / Average Target
+2.21%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OR Stock
Select your edition
All financial news and data tailored to specific country editions